These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

429 related items for PubMed ID: 1626572

  • 1. Very low doses of GM-CSF administered alone or with erythropoietin in aplastic anemia.
    Kurzrock R, Talpaz M, Gutterman JU.
    Am J Med; 1992 Jul; 93(1):41-8. PubMed ID: 1626572
    [Abstract] [Full Text] [Related]

  • 2. Differential dose-related haematological effects of GM-CSF in pancytopenia: evidence supporting the advantage of low- over high-dose administration in selected patients.
    Kurzrock R, Talpaz M, Gomez JA, Estey EH, O'Brien S, Hirsch-Ginsberg C, Koller C, Freireich EJ, Gutterman JU.
    Br J Haematol; 1991 Jul; 78(3):352-8. PubMed ID: 1873220
    [Abstract] [Full Text] [Related]

  • 3. Effects of low doses of recombinant human granulocyte-macrophage colony stimulating factor (GM-CSF) in patients with myelodysplastic syndromes.
    Estey EH, Kurzrock R, Talpaz M, McCredie KB, O'Brien S, Kantarjian HM, Keating MJ, Deisseroth AB, Gutterman JU.
    Br J Haematol; 1991 Mar; 77(3):291-5. PubMed ID: 2012752
    [Abstract] [Full Text] [Related]

  • 4. [Treatment of aplastic anemia with KRN8601 (rhG-CSF)].
    Kojima S, Matsuyama T, Miyazaki T, Sakurada K, Shike S, Okino E, Akabane T, Nakahata T, Okuni M, Mugishima H.
    Rinsho Ketsueki; 1990 Jul; 31(7):929-36. PubMed ID: 1699006
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Treatment of the anemia of aplastic anemia patients with recombinant human erythropoietin in combination with granulocyte colony-stimulating factor: a multicenter randomized controlled study. Multicenter Study Group.
    Bessho M, Hirashima K, Asano S, Ikeda Y, Ogawa N, Tomonaga M, Toyama K, Nakahata T, Nomura T, Mizoguchi H, Yoshida Y, Niitsu Y, Kohgo Y.
    Eur J Haematol; 1997 Apr; 58(4):265-72. PubMed ID: 9186538
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Combination therapy with recombinant human erythropoietin, interferon-alpha-2b and granulocyte-macrophage colony-stimulating factor in idiopathic myelofibrosis.
    Bourantas KL, Tsiara S, Christou L, Repousis P, Konstantinidou P, Bai M, Seferiadis K.
    Acta Haematol; 1996 Apr; 96(2):79-82. PubMed ID: 8701705
    [Abstract] [Full Text] [Related]

  • 14. Prevention of thrombocytopenia and neutropenia in a nonhuman primate model of marrow suppressive chemotherapy by combining pegylated recombinant human megakaryocyte growth and development factor and recombinant human granulocyte colony-stimulating factor.
    Harker LA, Marzec UM, Kelly AB, Cheung E, Tomer A, Nichol JL, Hanson SR, Stead RB.
    Blood; 1997 Jan 01; 89(1):155-65. PubMed ID: 8978288
    [Abstract] [Full Text] [Related]

  • 15. Contrasting effects of recombinant human granulocyte-macrophage colony-stimulating factor (CSF) and granulocyte CSF treatment on the cycling of blood elements in childhood-onset cyclic neutropenia.
    Wright DG, Kenney RF, Oette DH, LaRussa VF, Boxer LA, Malech HL.
    Blood; 1994 Aug 15; 84(4):1257-67. PubMed ID: 7519479
    [Abstract] [Full Text] [Related]

  • 16. Results of a phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor in very low birthweight neonates: significant induction of circulatory neutrophils, monocytes, platelets, and bone marrow neutrophils.
    Cairo MS, Christensen R, Sender LS, Ellis R, Rosenthal J, van de Ven C, Worcester C, Agosti JM.
    Blood; 1995 Oct 01; 86(7):2509-15. PubMed ID: 7670096
    [Abstract] [Full Text] [Related]

  • 17. Bilineage response in refractory aplastic anemia patients following long-term administration of recombinant human granulocyte colony-stimulating factor.
    Sonoda Y, Yashige H, Fujii H, Tsuda S, Maekawa T, Misawa S, Abe T.
    Eur J Haematol; 1992 Jan 01; 48(1):41-8. PubMed ID: 1730279
    [Abstract] [Full Text] [Related]

  • 18. Sequential interleukin 3 and granulocyte-macrophage-colony stimulating factor therapy in patients with bone marrow failure with long-term follow-up of responses.
    Wu HH, Talpaz M, Champlin RE, Pilat SR, Kurzrock R.
    Cancer; 2003 Dec 01; 98(11):2410-9. PubMed ID: 14635076
    [Abstract] [Full Text] [Related]

  • 19. Effect of recombinant human erythropoietin combined with granulocyte/ macrophage colony-stimulating factor in the treatment of patients with myelodysplastic syndrome. GM/EPO MDS Study Group.
    Thompson JA, Gilliland DG, Prchal JT, Bennett JM, Larholt K, Nelson RA, Rose EH, Dugan MH.
    Blood; 2000 Feb 15; 95(4):1175-9. PubMed ID: 10666187
    [Abstract] [Full Text] [Related]

  • 20. Use of recombinant GM-CSF following allogeneic BMTs for aplastic anemia.
    Chap L, Schiller G, Nimer SD.
    Bone Marrow Transplant; 1993 Aug 15; 12(2):173-5. PubMed ID: 8401368
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.